ASC Daily Briefing — July 7, 2026
🏥 New Today
CY 2027 OPPS/ASC Proposed Rule (CMS-1850-P) officially published in the Federal Register today — comment deadline now firm: August 31, 2026. The proposed rule (released July 2 and on public inspection since) published officially today, July 7, 2026 (Federal Register doc 2026-13656), starting the formal comment clock. The published notice sets the comment deadline at August 31, 2026 — earlier than the “on or about September 5” estimate carried in prior briefings. ASCs and management wishing to comment on the proposed 2.4% CY 2027 payment update, IPO-list Year 2 removals (638 services), ASCQR measure changes, or the botulinum-toxin prior-authorization expansion should calendar August 31, 2026 now. Source: Federal Register — CMS-1850-P (doc 2026-13656), published July 7, 2026
No new enforcement actions, accreditation announcements, or additional Federal Register ASC notices surfaced today. All other items — CY 2026 Final Rule in effect, IPO phase-out, ASCQR measure removals, price-transparency enforcement, Florida prior-authorization demonstration, AAAHC v44/v45, TJC Physical Environment consolidation, DNV as 4th CMS-approved ASC accreditor, CMS AO-oversight rule, Ascension–AmSurg divestitures — remain already captured on the Standing Compliance Reference or in recent briefings.